Etonitazene
| Etonitazene | |
|---|---|
| Salts [] | |
|---|---|
| Etonitazene hydrochloride | |
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 396.5 g/mol [1] |
| Predicted LogP | 4.3 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C22H28N4O3 [1] |
| IUPAC name | 2-[2-[(4-ethoxyphenyl)methyl]-5-nitrobenzimidazol-1-yl]-N,N-diethylethanamine [1] |
| SMILES | CCN(CC)CCN1C2=C(C=C(C=C2)[N+](=O)[O-])N=C1CC3=CC=C(C=C3)OCC [1] |
| InChI | InChI=1S/C22H28N4O3/c1-4-24(5-2)13-14-25-21-12-9-18(26(27)28)16-20(21)23-22(25)15-17-7-10-19(11-8-17)29-6-3/h7-12,16H,4-6,13-15H2,1-3H3 [1] |
| InChIKey | PXDBZSCGSQSKST-UHFFFAOYSA-N [1] |
Etonitazene (also known as Etonitazine, Etonitazeno, Ciba 20-684BA, ARC 1G2, Etonitazenum, NIH 7607, Etobedolum, Ba-20684, Acscn-9624 or NIH-7607) is a opioid substance of the nitazene class.
Chemistry
Salts []
Etonitazene is typically found in the form of its hydrochloride salt.
Stereochemistry []
Etonitazene is a achiral mixture.
Subjective effects []
Legal status []
- Brazil: Etonitazene is a A1 substance.[3]
- Canada: Etonitazene is a Schedule I substance.
- United Kingdom: Etonitazene is a Class A substance.
- United States: Etonitazene is a Schedule I under the "Controlled Substances Act (CSA)".
- Germany: Etonitazene is a Anlage I substance.
See also []
- Opioid
- Substituted nitazenes (zenes)
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 13493, Etonitazene. Accessed June 7, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/13493
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Etonitazene. UNII: 9U3GT3353T. Global Substance Registration System. Accessed June 7, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/9U3GT3353T
Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. March 31, 2023. Accessed June 7, 2026. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992